Eltoprazine: Phase IIb halted

Amarantus halted enrollment in a double-blind, placebo-controlled, 4-way crossover, international Phase IIb trial of oral eltoprazine in about 60 patients

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE